Skip to Main content Skip to Navigation
Journal articles

Androgen deprivation therapy prescription, blood and bone-density testing in a French population-based study exploring adherence to the French prostate cancer guidelines

Abstract : The safety profile of androgen deprivation therapy (ADT) is well known, and cardiovascular and osteoporosis risk factors should be assessed before ADT initiation. In order to examine whether the French Committee of Urologic Oncology prostate cancer (PCa) guidelines were properly followed by clinicians, including urologists, oncologists and radiotherapists, we used a nationwide comprehensive cohort of prostate cancer patients, who were new ADT users in 2011 and were followed up to 2013. Reimbursements for biological examinations and prescribers were identified, as well as PCa specialist consultations at drug initiation. Our results in this French cohort showed that the proportions of patients resorting to specialised care between one year and 3 months before ADT initiation and in the 6 months following was around 40 % for fasting glucose and 30 % for lipid assessments. Bone densitometry was performed on around 1% of patients. In the 12 months after ADT initiation, 75% of the patients were seen by a urologist and around 47% by an oncologist or a radiotherapist. Overall, there is still room for improvement in terms of ADT monitoring by clinicians and in the information provided to general practitioners and patients regarding the expected adverse effects of this treatment.
Complete list of metadatas

https://hal-univ-rennes1.archives-ouvertes.fr/hal-02564967
Contributor : Laurent Jonchère <>
Submitted on : Thursday, June 11, 2020 - 12:50:05 PM
Last modification on : Wednesday, August 26, 2020 - 3:07:38 PM

Identifiers

Citation

Lucie-Marie Scailteux, Frédéric Balusson, Emmanuel Oger, Sebastien Vincendeau, Romain Mathieu. Androgen deprivation therapy prescription, blood and bone-density testing in a French population-based study exploring adherence to the French prostate cancer guidelines. Minerva Urologica e Nefrologica, Edizione Minerva Medica, 2020, ⟨10.23736/S0393-2249.20.03683-8⟩. ⟨hal-02564967⟩

Share

Metrics

Record views

73

Files downloads

13